Upstream Peripheral Technologies Partners with Red One Medical to Facilitate Access of the GoBack Catheter to the VA Health System

0
214
GoBack versatile needle can be extended straight or to a curved position beyond the GoBack Catheter’s tip. The protrusion length is determined by the clinician with a thumb selector on the device’s handle. (Photo: Business Wire)

TAMPA, Fla.– Upstream Peripheral Technologies announced today that it has partnered with Red One Medical for the introduction of the GoBack® Crossing and Reentry Catheter to the VA Health System. The partnership will allow physicians in the VA Health System to have access to this new technology in treating patients suffering from advanced stages of peripheral arterial disease and critical limb threatening ischemia.

Dani Rottenberg, founder and CEO of Upstream, remarked, “Chronic Limb Total Occlusions are a nemesis for many patients and doctors. The GoBack is a versatile device that helps clinicians successfully treat patients with the most complex lesions. This partnership will help reach more patients and prevent more amputations.”

Red One Medical CEO Charles Pollak, commented, “We are excited for this partnership with Upstream Peripheral Technologies, to help serve and treat American Veterans who face critical debilitating amputations. All patients should have access to the most effective endovascular revascularization technologies, and this partnership will help in achieving this goal.”

The GoBack Catheter is a single-lumen crossing and reentry catheter which features a curved nitinol needle that serves as an effective crossing tool. The versatile needle can be extended straight or to a curved position beyond the GoBack Catheter’s tip. The protrusion length is determined by the clinician with a thumb selector on the device’s handle. The GoBack comes in two configurations of 4 French and 2.9 French for above and below the knee procedures. The GoBack has regulatory approval in 30 countries. Upstream will present the GoBack at the NCVH annual meeting in New Orleans, LA May 31-June 3.